{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T18:10:58Z","timestamp":1688235058564},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,5,12]],"date-time":"2013-05-12T00:00:00Z","timestamp":1368316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00011-013-0628-x","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T06:51:58Z","timestamp":1368255118000},"page":"733-742","source":"Crossref","is-referenced-by-count":2,"title":["The anti-inflammatory action of Bothrops jararaca snake antithrombin on acute inflammation induced by carrageenan in mice"],"prefix":"10.1007","volume":"62","author":[{"given":"Karen","family":"de Morais-Zani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Peixoto Barbosa","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacilene Barbosa","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio Jos\u00e9","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen Fernandes","family":"Grego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f4nica","family":"Lopes-Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparecida Sadae","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita Mitico","family":"Tanaka-Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,12]]},"reference":[{"issue":"12","key":"628_CR1","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1021\/cr010170+","volume":"102","author":"PG Gettins","year":"2002","unstructured":"Gettins PG. Serpin structure, mechanism, and function. Chem Rev. 2002;102(12):4751\u2013804. doi: cr010170 .","journal-title":"Chem Rev"},{"issue":"1","key":"628_CR2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0038-1657549","volume":"78","author":"TA Bayston","year":"1997","unstructured":"Bayston TA, Lane DA. Antithrombin: molecular basis of deficiency. Thromb Haemost. 1997;78(1):339\u201343.","journal-title":"Thromb Haemost"},{"issue":"8","key":"628_CR3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00001721-200212000-00001","volume":"13","author":"J Roemisch","year":"2002","unstructured":"Roemisch J, Gray E, Hoffmann JN, Wiedermann CJ. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis. 2002;13(8):657\u201370.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"628_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1563-2571.2002.02012.x","volume":"29","author":"ChJ Wiedermann","year":"2002","unstructured":"Wiedermann ChJ, Romisch J. The anti-inflammatory actions of antithrombin\u2013a review. Acta Med Austriaca. 2002;29(3):89\u201392.","journal-title":"Acta Med Austriaca"},{"issue":"1","key":"628_CR5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/bbrc.2001.5534","volume":"287","author":"NC Kaneider","year":"2001","unstructured":"Kaneider NC, Egger P, Dunzendorfer S, Wiedermann CJ. Syndecan-4 as antithrombin receptor of human neutrophils. Biochem Biophys Res Commun. 2001;287(1):42\u20136. doi: 10.1006\/bbrc.2001.5534 .","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 1","key":"628_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1242\/jcs.115.1.227","volume":"115","author":"NC Kaneider","year":"2002","unstructured":"Kaneider NC, Reinisch CM, Dunzendorfer S, Romisch J, Wiedermann CJ. Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J Cell Sci. 2002;115(Pt 1):227\u201336.","journal-title":"J Cell Sci"},{"issue":"7","key":"628_CR7","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.96.7.2302","volume":"96","author":"L Ostrovsky","year":"1997","unstructured":"Ostrovsky L, Woodman RC, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia\/reperfusion. Circulation. 1997;96(7):2302\u201310.","journal-title":"Circulation"},{"issue":"1\u20132","key":"628_CR8","first-page":"847","volume":"31","author":"XJ Zuo","year":"1999","unstructured":"Zuo XJ, Okada Y, Nicolaidou E, Toyoda T, Marchevsky A, Matloff JM, et al. Antithrombin III inhibits T and B lymphocyte activation in vitro and improves parameters of inflammation in a rat model of acute lung allograft rejection. Transplant Proc. 1999;31(1\u20132):847\u20138. doi: S0041-1345(98)01800-4 .","journal-title":"Transplant Proc"},{"issue":"1","key":"628_CR9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00003246-200201000-00031","volume":"30","author":"JN Hoffmann","year":"2002","unstructured":"Hoffmann JN, Vollmar B, Romisch J, Inthorn D, Schildberg FW, Menger MD. Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium. Crit Care Med. 2002;30(1):218\u201325.","journal-title":"Crit Care Med"},{"issue":"3","key":"628_CR10","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/0006-291X(89)91135-2","volume":"163","author":"T Yamauchi","year":"1989","unstructured":"Yamauchi T, Umeda F, Inoguchi T, Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun. 1989;163(3):1404\u201311.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"628_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-995820","volume":"24","author":"K Okajima","year":"1998","unstructured":"Okajima K, Uchiba M. The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin Thromb Hemost. 1998;24(1):27\u201332.","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"628_CR12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood.V97.4.1079","volume":"97","author":"S Dunzendorfer","year":"2001","unstructured":"Dunzendorfer S, Kaneider N, Rabensteiner A, Meierhofer C, Reinisch C, Romisch J, et al. Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood. 2001;97(4):1079\u201385.","journal-title":"Blood"},{"issue":"6","key":"628_CR13","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1161\/01.ATV.19.6.1566","volume":"19","author":"G Dickneite","year":"1999","unstructured":"Dickneite G, Leithauser B. Influence of antithrombin III on coagulation and inflammation in porcine septic shock. Arterioscler Thromb Vasc Biol. 1999;19(6):1566\u201372.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"628_CR14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0038-1651562","volume":"69","author":"G Dickneite","year":"1993","unstructured":"Dickneite G, Paques EP. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis. Thromb Haemost. 1993;69(2):98\u2013102.","journal-title":"Thromb Haemost"},{"issue":"7","key":"628_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00011-009-0155-y","volume":"59","author":"S Hagiwara","year":"2010","unstructured":"Hagiwara S, Iwasaka H, Shingu C, Matsumoto S, Uchida T, Noguchi T. High-dose antithrombin III prevents heat stroke by attenuating systemic inflammation in rats. Inflamm Res. 2010;59(7):511\u20138. doi: 10.1007\/s00011-009-0155-y .","journal-title":"Inflamm Res"},{"issue":"20","key":"628_CR16","first-page":"2466","volume":"122","author":"HM Sun","year":"2009","unstructured":"Sun HM, Hong LZ, Shen XK, Lin XQ, Song Y, Shi Y. Antithrombin-III without concomitant heparin improves endotoxin-induced acute lung injury rats by inhibiting the activation of mitogen-activated protein kinase. Chin Med J (Engl). 2009;122(20):2466\u201371.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"628_CR17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00024382-199808000-00002","volume":"10","author":"D Inthorn","year":"1998","unstructured":"Inthorn D, Hoffmann JN, Hartl WH, Muhlbayer D, Jochum M. Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis. Shock. 1998;10(2):90\u20136.","journal-title":"Shock"},{"issue":"8","key":"628_CR18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00134-005-2707-0","volume":"31","author":"T Iba","year":"2005","unstructured":"Iba T, Kidokoro A, Fukunaga M, Nagakari K, Suda M, Yoshikawa S, et al. Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin. Intensive Care Med. 2005;31(8):1101\u20138. doi: 10.1007\/s00134-005-2707-0 .","journal-title":"Intensive Care Med"},{"issue":"15","key":"628_CR19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","volume":"286","author":"BL Warren","year":"2001","unstructured":"Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, et al. Caring for the critically ill patient: high-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA. 2001;286(15):1869\u201378. doi: jce10000 .","journal-title":"JAMA"},{"issue":"2","key":"628_CR20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.CCM.0000194731.08896.99","volume":"34","author":"CJ Wiedermann","year":"2006","unstructured":"Wiedermann CJ, Hoffmann JN, Juers M, Ostermann H, Kienast J, Briegel J, et al. High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety. Crit Care Med. 2006;34(2):285\u201392. doi: 00003246-200602000-00001 .","journal-title":"Crit Care Med"},{"issue":"2","key":"628_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cbpb.2008.11.002","volume":"152","author":"KB Morais de","year":"2009","unstructured":"de Morais KB, Vieira CO, Hirata IY, Tanaka-Azevedo AM. Bothrops jararaca antithrombin: isolation, characterization and comparison with other animal antithrombins. Comp Biochem Physiol B: Biochem Mol Biol. 2009;152(2):171\u20136.","journal-title":"Comp Biochem Physiol B: Biochem Mol Biol"},{"issue":"5","key":"628_CR22","first-page":"249","volume":"20","author":"K Morais-Zani","year":"2009","unstructured":"Morais-Zani K, Tanaka AS, Tanaka-Azevedo AM. Isolation of Bothrops jararaca snake antithrombin from the supernatant of fibrinogen purification. J Biomol Tech. 2009;20(5):249\u201352.","journal-title":"J Biomol Tech"},{"key":"628_CR23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0076-6879(90)82008-P","volume":"182","author":"CM Stoscheck","year":"1990","unstructured":"Stoscheck CM. Quantification of protein. Methods Enzymol. 1990;182:50\u201368.","journal-title":"Methods Enzymol"},{"issue":"1","key":"628_CR24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150(1):76\u201385.","journal-title":"Anal Biochem"},{"issue":"259","key":"628_CR25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(259):680\u20135.","journal-title":"Nature"},{"issue":"5","key":"628_CR26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","volume":"68","author":"A Shevchenko","year":"1996","unstructured":"Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1996;68(5):850\u20138.","journal-title":"Anal Chem"},{"issue":"11","key":"628_CR27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0024-3205(69)90021-6","volume":"8","author":"L Levy","year":"1969","unstructured":"Levy L. Carrageenan paw edema in the mouse. Life Sci. 1969;8(11):601\u20136.","journal-title":"Life Sci"},{"key":"628_CR28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-0-12-138902-4.50021-0","volume-title":"Venomous animals and their venoms","author":"G Rosenfeld","year":"1971","unstructured":"Rosenfeld G. Symptomatology, pathology and treatment of snake bites in South America. In: Burcherl W, Buckley EE, Deulofeu V, editors. Venomous animals and their venoms. New York: Academic Press; 1971. p. 345\u2013841."},{"issue":"3","key":"628_CR29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0026-2862(73)90054-X","volume":"5","author":"S Baez","year":"1973","unstructured":"Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res. 1973;5(3):384\u201394.","journal-title":"Microvasc Res"},{"issue":"1","key":"628_CR30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0041-0101(94)90020-5","volume":"32","author":"B Lomonte","year":"1994","unstructured":"Lomonte B, Lundgren J, Johansson B, Bagge U. The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study. Toxicon. 1994;32(1):41\u201355.","journal-title":"Toxicon"},{"issue":"5435","key":"628_CR31","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.285.5435.1861","volume":"285","author":"RW Carrell","year":"1999","unstructured":"Carrell RW. How serpins are shaping up. Science. 1999;285(5435):1861.","journal-title":"Science"},{"issue":"5","key":"628_CR32","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/S0021-9258(18)34938-X","volume":"257","author":"I Bjork","year":"1982","unstructured":"Bjork I, Jackson CM, Jornvall H, Lavine KK, Nordling K, Salsgiver WJ. The active site of antithrombin: release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin. J Biol Chem. 1982;257(5):2406\u201311.","journal-title":"J Biol Chem"},{"issue":"4","key":"628_CR33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cbpb.2008.08.012","volume":"151","author":"CO Vieira","year":"2008","unstructured":"Vieira CO, Tanaka AS, Sano-Martins IS, Morais KB, Santoro ML, Tanaka-Azevedo AM. Bothrops jararaca fibrinogen and its resistance to hydrolysis evoked by snake venoms. Comp Biochem Physiol B: Biochem Mol Biol. 2008;151(4):428\u201332.","journal-title":"Comp Biochem Physiol B: Biochem Mol Biol"},{"issue":"4","key":"628_CR34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0006-291X(03)01464-5","volume":"308","author":"AM Tanaka-Azevedo","year":"2003","unstructured":"Tanaka-Azevedo AM, Tanaka AS, Sano-Martins IS. A new blood coagulation inhibitor from the snake Bothrops jararaca plasma: isolation and characterization. Biochem Biophys Res Commun. 2003;308(4):706\u201312.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"628_CR35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.toxicon.2004.06.001","volume":"44","author":"AM Tanaka-Azevedo","year":"2004","unstructured":"Tanaka-Azevedo AM, Torquato RJ, Tanaka AS, Sano-Martins IS. Characterization of Bothrops jararaca coagulation inhibitor (BjI) and presence of similar protein in plasma of other animals. Toxicon. 2004;44(3):289\u201394.","journal-title":"Toxicon"},{"issue":"2","key":"628_CR36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cbpb.2007.09.011","volume":"149","author":"KB Morais","year":"2008","unstructured":"Morais KB, Grego KF, Tanaka-Azevedo AM. Identification of proteins similar to Bothrops jararaca coagulation inhibitor (BjI) in the plasmas of Bothrops alternatus, Bothrops jararacussu and Crotalus durissus terrificus snakes. Comp Biochem Physiol B: Biochem Mol Biol. 2008;149(2):236\u201340. doi: 10.1016\/j.cbpb.2007.09.011 .","journal-title":"Comp Biochem Physiol B: Biochem Mol Biol"},{"key":"628_CR37","first-page":"115","volume":"225","author":"CJ Morris","year":"2003","unstructured":"Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol. 2003;225:115\u201321. doi: 10.1385\/1-59259-374-7:115 .","journal-title":"Methods Mol Biol"},{"key":"628_CR38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00011-012-0557-0","volume":"62","author":"MM Sitonio","year":"2013","unstructured":"Sitonio MM, de Carvalho Junior CH, Campos ID, Silva JB, de Lima MD, Goes AJ, et al. Anti-inflammatory and anti-arthritic activities of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (beta-lapachone). Inflamm Res. 2013;62:107\u201313. doi: 10.1007\/s00011-012-0557-0 .","journal-title":"Inflamm Res"},{"key":"628_CR39","unstructured":"Henriques MG, Silva PM, Martins MA, Flores CA, Cunha FQ, Assreuy-Filho J et al. Mouse paw edema: a new model for inflammation? Brazilian J Med Biol Res\u00a01987;20(2):243\u20139."},{"key":"628_CR40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.taap.2012.07.032","volume":"264","author":"N Chatterjee","year":"2012","unstructured":"Chatterjee N, Das S, Bose D, Banerjee S, Chattopadhyay D, Saha KD. Exploring the anti-inflammatory activity of a novel 2-phenylquinazoline analog with protection against inflammatory injury. Toxicol Appl Pharmacol. 2012;264:181\u201394. doi: 10.1016\/j.taap.2012.07.032 .","journal-title":"Toxicol Appl Pharmacol"},{"key":"628_CR41","author":"DT Meneguzzo","year":"2012","unstructured":"Meneguzzo DT, Lopes LA, Pallota R, Soares-Ferreira L, Lopes-Martins RA, Ribeiro MS. Prevention and treatment of mice paw edema by near-infrared low-level laser therapy on lymph nodes. Lasers Med Sci. 2012;. doi: 10.1007\/s10103-012-1163-7 .","journal-title":"Lasers Med Sci"},{"issue":"2","key":"628_CR42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1734-1140(12)70766-1","volume":"64","author":"JA Rodrigues","year":"2012","unstructured":"Rodrigues JA, Vanderlei ES, Silva LM, Araujo IW, Queiroz IN, Paula GA, et al. Antinociceptive and anti-inflammatory activities of a sulfated polysaccharide isolated from the green seaweed Caulerpa cupressoides. Pharm Reports: PR. 2012;64(2):282\u201392.","journal-title":"Pharm Reports: PR"},{"issue":"3","key":"628_CR43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pbb.2012.02.012","volume":"101","author":"AM Godin","year":"2012","unstructured":"Godin AM, Ferreira WC, Rocha LT, Ferreira RG, Paiva AL, Merlo LA, et al. Nicotinic acid induces antinociceptive and anti-inflammatory effects in different experimental models. Pharmacol Biochem Behav. 2012;101(3):493\u20138. doi: 10.1016\/j.pbb.2012.02.012 .","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"628_CR44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjp.0705650","volume":"142","author":"I Posadas","year":"2004","unstructured":"Posadas I, Bucci M, Roviezzo F, Rossi A, Parente L, Sautebin L, et al. Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br J Pharmacol. 2004;142(2):331\u20138. doi: 10.1038\/sj.bjp.0705650 .","journal-title":"Br J Pharmacol"},{"issue":"1","key":"628_CR45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V93.1.157","volume":"93","author":"N Harada","year":"1999","unstructured":"Harada N, Okajima K, Kushimoto S, Isobe H, Tanaka K. Antithrombin reduces ischemia\/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood. 1999;93(1):157\u201364.","journal-title":"Blood"},{"issue":"11","key":"628_CR46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJM198709103171107","volume":"317","author":"HL Malech","year":"1987","unstructured":"Malech HL, Gallin JI. Current concepts: immunology. Neutrophils in human diseases. N Engl J Med. 1987;317(11):687\u201394. doi: 10.1056\/NEJM198709103171107 .","journal-title":"N Engl J Med"},{"issue":"8","key":"628_CR47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0196-9781(99)00086-8","volume":"20","author":"TS Saleh","year":"1999","unstructured":"Saleh TS, Calixto JB, Medeiros YS. Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides. 1999;20(8):949\u201356.","journal-title":"Peptides"},{"issue":"6","key":"628_CR48","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.4049\/jimmunol.147.6.1803","volume":"147","author":"I Utsunomiya","year":"1991","unstructured":"Utsunomiya I, Nagai S, Oh-ishi S. Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy. J Immunol. 1991;147(6):1803\u20139.","journal-title":"J Immunol"},{"issue":"9","key":"628_CR49","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.163.9.5094","volume":"163","author":"S Cuzzocrea","year":"1999","unstructured":"Cuzzocrea S, Sautebin L, De Sarro G, Costantino G, Rombola L, Mazzon E, et al. Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J Immunol. 1999;163(9):5094\u2013104.","journal-title":"J Immunol"},{"issue":"1","key":"628_CR50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00003246-200101000-00027","volume":"29","author":"PJ Souter","year":"2001","unstructured":"Souter PJ, Thomas S, Hubbard AR, Poole S, Romisch J, Gray E. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med. 2001;29(1):134\u20139.","journal-title":"Crit Care Med"},{"issue":"5","key":"628_CR51","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0092-8674(91)90393-D","volume":"65","author":"MB Lawrence","year":"1991","unstructured":"Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991;65(5):859\u201373.","journal-title":"Cell"},{"issue":"7","key":"628_CR52","first-page":"1553","volume":"42","author":"K Yamashiro","year":"2001","unstructured":"Yamashiro K, Kiryu J, Tsujikawa A, Honjo M, Nonaka A, Miyamoto K, et al. Inhibitory effects of antithrombin III against leukocyte rolling and infiltration during endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 2001;42(7):1553\u201360.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"628_CR53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/039463200401700104","volume":"17","author":"D Gritti","year":"2004","unstructured":"Gritti D, Malinverno A, Gasparetto C, Wiedermann CJ, Ricevuti R. Attenuation of leukocyte beta 2-integrin expression by antithrombin-III. Int J Immunopathol Pharmacol. 2004;17(1):27\u201332.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"628_CR54","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0049-3848(90)90113-Q","volume":"59","author":"S Horie","year":"1990","unstructured":"Horie S, Ishii H, Kazama M. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells. Thromb Res. 1990;59(6):895\u2013904.","journal-title":"Thromb Res"},{"issue":"1","key":"628_CR55","doi-asserted-by":"crossref","first-page":"C98","DOI":"10.1152\/ajpcell.2000.279.1.C98","volume":"279","author":"JN Hoffmann","year":"2000","unstructured":"Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD. Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway. Am J Physiol Cell Physiol. 2000;279(1):C98\u2013107.","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-013-0628-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-013-0628-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-013-0628-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T17:30:34Z","timestamp":1688232634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-013-0628-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,12]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1007\/s00011-013-0628-x","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,12]]}}}